SEC Form 4 research
| Issuer | Alto Neuroscience, Inc. |
|---|---|
| Tickers | ANRO |
| Reporting owners | 20 |
| Officers and directors | 3 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-09-30 | Smith Nicholas Conrad | S | 886 | $26.87 | Not reported |
| 2026-10-01 | 2026-09-30 | Smith Nicholas Conrad | S | 23,170 | $25.78 | Not reported |
| 2026-10-01 | 2026-09-29 | Smith Nicholas Conrad | S | 110,830 | $26.58 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.